Wosulin 30/70/Wosulin N/Wosulin R Dosage/Direction for Use

Posology: The dosage should be determined by the physician, according to the requirement of the patient.
Paediatric population: No data are available.
Method of Administration: Wosulin R, Wosulin N and Wosulin 30/70 is only suitable for subcutaneous injections from a reusable pen. This formulation should not be administered intravenously.
Subcutaneous administration should be in the upper arms, thighs, buttocks, or abdomen. Use of injection sites should be rotated so that the same site is not used more than approximately once a month.
Care should be taken when injecting any insulin preparations to ensure that a blood vessel has not been entered. After any insulin injection, the injection site should not be massaged. Patients must be educated to use proper injection techniques.
Wosulin N may be administered in combination with Wosulin R.
Wosulin 30/70 formulation is a ready-made defined mixture of soluble and isophane insulin designed to avoid the need for the patient to mix insulin preparations. A patient's treatment regimen should be based on their individual metabolic requirements